Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_assertion type Assertion NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_head.
- NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_assertion description "[In inflammatory bowel disease (IBD), 6-TGN levels in the target range of 235-400 pmol/8x10(8) red blood cells (RBC) are associated with a high likelihood of response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_provenance.
- NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_assertion evidence source_evidence_literature NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_provenance.
- NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_assertion SIO_000772 19040311 NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_provenance.
- NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_assertion wasDerivedFrom befree-20140225 NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_provenance.
- NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_assertion wasGeneratedBy ECO_0000203 NP928187.RADgNduaS7LAkouDjcSqTFBhMxdWF--TykyIZC1rhYFLI130_provenance.